Tianjin Zhongxin Pharmaceutical Group Corp Ltd (600329) — Cash Flow-to-Debt Ratio
Tianjin Zhongxin Pharmaceutical Group Corp Ltd (600329) has a Cash Flow-to-Debt Ratio of 0.04x as of September 2025, meaning its operating cash flow of CN¥110.78 Million could theoretically repay 0% of its total liabilities (CN¥2.56 Billion) in one year. See 600329 cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Tianjin Zhongxin Pharmaceutical Group Corp Ltd Cash Flow-to-Debt Ratio (2001–2024)
Historical debt coverage capacity for Tianjin Zhongxin Pharmaceutical Group Corp Ltd across 24 annual periods. Also explore net asset momentum of Tianjin Zhongxin Pharmaceutical Group Co to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Tianjin Zhongxin Pharmaceutical Group Corp Ltd (2001–2024)
Year-by-year debt coverage analysis for Tianjin Zhongxin Pharmaceutical Group Corp Ltd. For market capitalisation and broader financial context, see market value of Tianjin Zhongxin Pharmaceutical Group Co.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.32x | CN¥924.67 Million | CN¥2.92 Billion | ▲ +65.0% |
| 2023 | 0.19x | CN¥688.49 Million | CN¥3.58 Billion | ▲ +2.2% |
| 2022 | 0.19x | CN¥677.25 Million | CN¥3.61 Billion | ▼ -43.7% |
| 2021 | 0.33x | CN¥852.40 Million | CN¥2.55 Billion | ▲ +16.0% |
| 2020 | 0.29x | CN¥671.42 Million | CN¥2.33 Billion | ▲ +34.7% |
| 2019 | 0.21x | CN¥495.49 Million | CN¥2.32 Billion | ▲ +25.1% |
| 2018 | 0.17x | CN¥350.14 Million | CN¥2.05 Billion | ▲ +8679.3% |
| 2017 | 0.00x | CN¥-3.97 Million | CN¥2.00 Billion | ▼ -101.0% |
| 2016 | 0.20x | CN¥419.90 Million | CN¥2.06 Billion | ▲ +11.1% |
| 2015 | 0.18x | CN¥360.58 Million | CN¥1.96 Billion | ▲ +59.4% |
| 2014 | 0.12x | CN¥286.85 Million | CN¥2.49 Billion | ▲ +45.0% |
| 2013 | 0.08x | CN¥213.44 Million | CN¥2.69 Billion | ▲ +717.4% |
| 2012 | 0.01x | CN¥20.81 Million | CN¥2.14 Billion | ▼ -89.2% |
| 2011 | 0.09x | CN¥173.88 Million | CN¥1.94 Billion | ▲ +12.9% |
| 2010 | 0.08x | CN¥139.04 Million | CN¥1.75 Billion | ▲ +79.0% |
| 2009 | 0.04x | CN¥83.41 Million | CN¥1.88 Billion | ▼ -43.8% |
| 2008 | 0.08x | CN¥155.77 Million | CN¥1.97 Billion | ▲ +734.4% |
| 2007 | 0.01x | CN¥20.13 Million | CN¥2.13 Billion | ▲ +170.7% |
| 2006 | -0.01x | CN¥-28.08 Million | CN¥2.10 Billion | ▼ -110.8% |
| 2005 | 0.12x | CN¥261.91 Million | CN¥2.11 Billion | ▲ +2310.9% |
| 2004 | 0.01x | CN¥10.50 Million | CN¥2.04 Billion | ▼ -86.8% |
| 2003 | 0.04x | CN¥76.57 Million | CN¥1.96 Billion | ▼ -72.5% |
| 2002 | 0.14x | CN¥187.60 Million | CN¥1.32 Billion | ▲ +6.3% |
| 2001 | 0.13x | CN¥157.73 Million | CN¥1.18 Billion | — |